Bio Path Holdings (BPTH) Stock Price

Bio Path Holdings Price

NASDAQ·CLOSED
0.04USD+0.00 (+0.00 %)
Market closed

Revenue at Bio Path Holdings has contracted by 3.9% per year over the past 12 years to 37,000.00 USD. For Bio Path Holdings, the net margin of -18,981.1% is down versus -142.2% a few years ago. The consensus 12-month price target for Bio Path Holdings is 2.04 USD, about 5,000.0% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus. The stock trades about 100% above its 52-week low.

Bio Path Holdings stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Bio Path Holdings over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Bio Path Holdings stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Bio Path Holdings's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Bio Path Holdings Stock Price History
DateBio Path Holdings Price
7/31/20260.04 USD
7/30/20260.04 USD
7/29/20260.04 USD
7/28/20260.04 USD
7/27/20260.04 USD
7/23/20260.04 USD
7/22/20260.04 USD
7/21/20260.04 USD
7/20/20260.04 USD
7/17/20260.04 USD
7/16/20260.04 USD
7/15/20260.04 USD
7/14/20260.04 USD
7/13/20260.04 USD
7/10/20260.04 USD
7/9/20260.04 USD
7/8/20260.04 USD
7/7/20260.04 USD
7/6/20260.04 USD
7/2/20260.05 USD
7/1/20260.04 USD
6/30/20260.05 USD
6/29/20260.03 USD
6/26/20260.03 USD
6/25/20260.04 USD
6/24/20260.04 USD
6/23/20260.04 USD
6/22/20260.03 USD
6/18/20260.04 USD
6/17/20260.04 USD
6/16/20260.05 USD
6/15/20260.04 USD
6/12/20260.04 USD
6/11/20260.04 USD
6/10/20260.04 USD
6/9/20260.04 USD
6/8/20260.03 USD
6/5/20260.04 USD
6/4/20260.03 USD
6/3/20260.03 USD
6/2/20260.04 USD
6/1/20260.04 USD
5/29/20260.03 USD
5/28/20260.04 USD
5/27/20260.04 USD
5/26/20260.04 USD
5/22/20260.04 USD
5/21/20260.03 USD
5/20/20260.03 USD
5/19/20260.02 USD
5/18/20260.04 USD
5/15/20260.04 USD
5/14/20260.03 USD
5/13/20260.03 USD
5/12/20260.04 USD
5/11/20260.05 USD
5/8/20260.05 USD
5/7/20260.06 USD
5/6/20260.06 USD
5/5/20260.06 USD
5/1/20260.06 USD
4/30/20260.06 USD
4/29/20260.06 USD
4/28/20260.06 USD
4/27/20260.06 USD
4/23/20260.06 USD
4/22/20260.06 USD
4/21/20260.06 USD
4/20/20260.05 USD
4/17/20260.07 USD
4/16/20260.06 USD
4/15/20260.06 USD
4/14/20260.06 USD
4/13/20260.06 USD
4/10/20260.06 USD
4/9/20260.06 USD
4/8/20260.05 USD
4/7/20260.05 USD
4/6/20260.06 USD
4/2/20260.06 USD
4/1/20260.06 USD
3/31/20260.06 USD
3/30/20260.06 USD
3/27/20260.06 USD
3/26/20260.07 USD
3/25/20260.07 USD
3/24/20260.07 USD
3/23/20260.07 USD
3/20/20260.06 USD
3/19/20260.06 USD
3/18/20260.06 USD
3/17/20260.06 USD
3/16/20260.06 USD
3/13/20260.07 USD
3/12/20260.07 USD
3/11/20260.07 USD
3/10/20260.07 USD
3/9/20260.06 USD
3/6/20260.06 USD
3/5/20260.06 USD
3/4/20260.06 USD
3/3/20260.06 USD
3/2/20260.07 USD
2/27/20260.06 USD
2/26/20260.06 USD
2/25/20260.06 USD
2/24/20260.07 USD
2/23/20260.07 USD
2/20/20260.07 USD
2/19/20260.07 USD
2/18/20260.07 USD
2/17/20260.06 USD
2/13/20260.06 USD
2/12/20260.06 USD
2/11/20260.07 USD
2/10/20260.07 USD
2/9/20260.06 USD
2/6/20260.06 USD
2/5/20260.06 USD
2/4/20260.06 USD
2/3/20260.06 USD
2/2/20260.07 USD
1/30/20260.06 USD
1/29/20260.06 USD
1/28/20260.07 USD
1/27/20260.06 USD
1/26/20260.06 USD
1/23/20260.06 USD
1/22/20260.07 USD
1/21/20260.06 USD
1/20/20260.05 USD
1/16/20260.05 USD
1/15/20260.06 USD
1/14/20260.06 USD
1/13/20260.05 USD
1/12/20260.05 USD
1/9/20260.06 USD
1/8/20260.06 USD
1/7/20260.06 USD
1/6/20260.06 USD
1/5/20260.07 USD
1/2/20260.06 USD
12/31/20250.06 USD
12/30/20250.06 USD
12/29/20250.07 USD
12/26/20250.07 USD
12/24/20250.07 USD
12/23/20250.07 USD
12/22/20250.07 USD
12/19/20250.07 USD
12/18/20250.07 USD
12/17/20250.07 USD
12/16/20250.08 USD
12/15/20250.08 USD
12/12/20250.08 USD
12/11/20250.08 USD
12/10/20250.07 USD
12/9/20250.07 USD
12/8/20250.09 USD
12/5/20250.09 USD
12/4/20250.07 USD
12/3/20250.07 USD
12/2/20250.07 USD
12/1/20250.07 USD
11/28/20250.07 USD
11/26/20250.07 USD
11/25/20250.07 USD
11/24/20250.09 USD
11/21/20250.08 USD
11/20/20250.07 USD
11/19/20250.08 USD
11/18/20250.08 USD
11/17/20250.09 USD
11/14/20250.10 USD
11/13/20250.09 USD
11/12/20250.09 USD
11/11/20250.09 USD
11/10/20250.09 USD
11/7/20250.09 USD
11/6/20250.09 USD
11/5/20250.09 USD
11/4/20250.09 USD
11/3/20250.09 USD
10/31/20250.10 USD
10/30/20250.09 USD
10/29/20250.09 USD
10/28/20250.09 USD
10/27/20250.10 USD
10/24/20250.08 USD
10/23/20250.08 USD
10/22/20250.08 USD
10/21/20250.08 USD
10/20/20250.08 USD
10/17/20250.06 USD
10/16/20250.08 USD
10/15/20250.08 USD
10/14/20250.07 USD
10/13/20250.07 USD
10/10/20250.07 USD
10/9/20250.07 USD
10/8/20250.07 USD
10/7/20250.07 USD
10/6/20250.06 USD
10/3/20250.06 USD
10/2/20250.07 USD
10/1/20250.07 USD
9/30/20250.06 USD
9/29/20250.07 USD
9/26/20250.07 USD
9/25/20250.07 USD
9/24/20250.06 USD
9/23/20250.06 USD
9/22/20250.05 USD
9/19/20250.06 USD
9/18/20250.06 USD
9/17/20250.06 USD
9/16/20250.06 USD
9/15/20250.06 USD
9/12/20250.06 USD
9/11/20250.07 USD
9/10/20250.08 USD
9/9/20250.08 USD
9/8/20250.11 USD
9/5/20250.12 USD
9/4/20250.13 USD
9/3/20250.12 USD
9/2/20250.13 USD
8/29/20250.11 USD
8/28/20250.12 USD
8/27/20250.10 USD
8/26/20250.11 USD
8/25/20250.10 USD
8/22/20250.12 USD
8/21/20250.12 USD
8/20/20250.12 USD
8/19/20250.11 USD
8/18/20250.13 USD
8/15/20250.13 USD
8/14/20250.14 USD
8/13/20250.14 USD
8/12/20250.14 USD
8/11/20250.14 USD
8/8/20250.14 USD
8/7/20250.14 USD
8/6/20250.14 USD
8/5/20250.14 USD
Access this data via the Eulerpool API
Get Free API Key

Bio Path Holdings Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
0.00 USD
-13.90 M USD
-13.84 M USD
Jan 1, 2023
0.00 USD
-15.84 M USD
-16.08 M USD
Jan 1, 2024
0.00 USD
-11.99 M USD
-9.89 M USD
Jan 1, 2025 (e)
21.61 M USD
-13.42 M USD
-760,020.00 USD
Jan 1, 2026 (e)
40.06 M USD
-13.66 M USD
-678,759.93 USD
Jan 1, 2027 (e)
39.84 M USD
-13.91 M USD
-654,859.96 USD
Jan 1, 2028 (e)
48.33 M USD
35.14 M USD
717,000.00 USD
Jan 1, 2029 (e)
73.41 M USD
60.46 M USD
1.02 M USD

Bio Path Holdings Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 5, 2026, 11:16 AM
 
REVENUEM USD
REVENUE GROWTH%
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
201420152016201720182019202020212022202320242025e2026e2027e2028e2029e
–––––––––––21.0040.0039.0048.0073.00
––––––––––––90.48-2.5023.0852.08
-4.00-5.00-8.00-8.00-8.00-8.00-10.00-10.00-13.00-15.00-11.00-13.00-13.00-13.0035.0060.00
–––––––––––-61.90-32.50-33.3372.9282.19
-4.00-5.00-6.00-7.00-8.00-8.00-10.00-10.00-13.00-16.00-9.00––––1.00
33.3325.0020.0016.6714.29–25.00–30.0023.08-43.75–––––
0.450.450.460.570.602.663.856.730.360.623.023.023.023.023.023.02
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Bio Path Holdings generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Bio Path Holdings retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Bio Path Holdings's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Bio Path Holdings has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Bio Path Holdings's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Bio Path Holdings stock margins

The Bio Path Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bio Path Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bio Path Holdings.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
100.00 %
- %
- %
Jan 1, 2021
100.00 %
- %
- %
Jan 1, 2022
100.00 %
- %
- %
Jan 1, 2023
100.00 %
- %
- %
Jan 1, 2024
100.00 %
- %
- %
Jan 1, 2025 (e)
100.00 %
-62.12 %
-3.52 %
Jan 1, 2026 (e)
100.00 %
-34.11 %
-1.69 %
Jan 1, 2027 (e)
100.00 %
-34.91 %
-1.64 %

Bio Path Holdings Stock Revenue, EBIT, Earnings per Share

The Bio Path Holdings earnings per share therefore indicates how much revenue Bio Path Holdings has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
0.00 USD
-2.84 USD
-2.82 USD
Jan 1, 2021
0.00 USD
-1.55 USD
-1.55 USD
Jan 1, 2022
0.00 USD
-38.83 USD
-38.65 USD
Jan 1, 2023
0.00 USD
-25.64 USD
-26.02 USD
Jan 1, 2024
0.00 USD
-3.97 USD
-3.28 USD
Jan 1, 2025 (e)
45.20 USD
-4.45 USD
-1.59 USD
Jan 1, 2026 (e)
83.80 USD
-4.53 USD
-1.42 USD
Jan 1, 2027 (e)
83.35 USD
-4.61 USD
-1.37 USD

Bio Path Holdings business model & stock analysis

Bio Path Holdings Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Bio Path Holdings Employees
Details
Date
Bio Path Holdings Employees
Jan 1, 2017
- Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees

Bio Path Holdings Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Bio Path Holdings historical P/E ratio, EBIT multiple, and P/S ratio

Bio Path Holdings annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Bio Path Holdings shares outstanding

The number of shares of Bio Path Holdings was 3.02 M in 2025. This indicates how many shares Bio Path Holdings is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
3.85 M Stocks
Jan 1, 2021
6.73 M Stocks
Jan 1, 2022
358,000.00 Stocks
Jan 1, 2023
618,000.00 Stocks
Jan 1, 2024
3.02 M Stocks
Jan 1, 2025 (e)
3.02 M Stocks
Jan 1, 2026 (e)
3.02 M Stocks
Jan 1, 2027 (e)
3.02 M Stocks

Bio Path Holdings stock splits

In Bio Path Holdings's history, there have been no stock splits.

Current Bio Path Holdings forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
85.71 % (6)
Hold
14.29 % (1)
Sell
0.00 % (0)
12M Price Target
2.04
Last Price
0.04
Currency
USD
12M Return Potential
5,268.42 %
LTM Return
0 %

Bio Path Holdings Analyst Rating Actions

DateFirmActionRating
7/8/2024
Roth MKM
Roth MKM
MaintainedBuy
4/18/2024
Roth MKM
Roth MKM
MaintainedBuy
3/27/2024
Roth MKM
Roth MKM
MaintainedBuy
5/18/2022
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy
3/11/2021
Roth Capital
Roth Capital
MaintainedBuy
11/25/2020
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy
11/25/2020
H.C. Wainwright
H.C. Wainwright
MaintainedBuy
11/15/2020
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy
8/16/2020
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy
5/18/2020
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy

Bio Path Holdings Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
3/25/2026-0.41USD-0.00USD-2025 Q4
11/13/2025-0.41USD-0.00USD-2025 Q3
8/13/2025-0.41USD-0.00USD-2025 Q2
11/15/2024-1.04USD-0.00USD-2024 Q3
5/10/2024-0.24USD-0.00USD-2024 Q1
3/29/2024-0.28USD-0.00USD-2023 Q4
11/13/2023-0.42USD-0.00USD-2023 Q3
8/14/2023-0.45USD-0.00USD-2023 Q2
5/15/2023-0.52USD-0.00USD-2023 Q1
3/9/2023-0.43USD-0.00USD-2022 Q4

Bio Path Holdings shareholder structure

% Name
0.00000%
Allworth Financial, L.P.
Allworth Financial, L.P.
0.00000%
Apollon Wealth Management, LLC
Apollon Wealth Management, LLC
0.00000%
Armistice Capital LLC
Armistice Capital LLC
0.00000%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
0.00000%
BofA Global Research (US)
BofA Global Research (US)
0.00000%
Cetera Investment Advisers LLC
Cetera Investment Advisers LLC

Bio Path Holdings Beneficial Ownership Filings (SEC 13D/G)

Free Float
100.0%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
9.27%
Ryan M. Lane
Ryan M. Lane
SEC ↗
9.27%
Martin D. Hoe
Martin D. Hoe
SEC ↗
9.27%
Empery Asset Management, LP
Empery Asset Management, LP
SEC ↗
7.10%
Mitchell P. Kopin
Mitchell P. Kopin
SEC ↗
7.10%
Intracoastal Capital LLC
Intracoastal Capital LLC
SEC ↗
7.10%
Daniel B. Asher
Daniel B. Asher
SEC ↗
6.10%
Winson
Winson
SEC ↗
6.10%
Nathoo
Nathoo
SEC ↗
6.10%
Kassam
Kassam
SEC ↗
5.90%
5.9% (1)
5.9% (1)
SEC ↗

Bio Path Holdings Executives and Management Board

1 members · 0 % women

VG

Mr. Vikram Grover

President, Chief Executive Officer, Chief Financial Officer, Director · since 2025

–

Frequently asked questions about Bio Path Holdings

Analysts currently set an average price target of 2.04 USD for the Bio Path Holdings stock (median: 2.04 USD), implying +5,268.4 % versus the latest price. The consensus is based on 7 analyst ratings.

Bio Path Holdings Analyst Price Targets 2026

7 analysts currently rate the Bio Path Holdings stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Bio Path Holdings to generate revenue of 40.06 M USD and earnings per share of -0.22 USD.

Bio Path Holdings Analyst Price Targets 2026

Converted at the current exchange rate, the Bio Path Holdings share trades at 0.03 EUR (0.04 USD).

The Bio Path Holdings share (BPTH) is listed on 2 stock exchanges, including: NASDAQ (BPTH), Frankfurt (IBPB.F).

No history available for Bio Path Holdings.

The expected revenue of Bio Path Holdings is 40.06 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Bio Path Holdings is -678,759.93 USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Bio Path Holdings is currently -0.18. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Bio Path Holdings stock.

The price-to-sales ratio (P/S) of Bio Path Holdings is currently 0.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Bio Path Holdings stock.

The Eulerpool Quality Score for Bio Path Holdings is 2/10.

The ISIN of Bio Path Holdings is US09057N4097. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Bio Path Holdings is A2PB4K. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Bio Path Holdings is BPTH. The ticker symbol is used to trade Bio Path Holdings shares on the stock exchange.

Bio Path Holdings paid dividends every year for the past 0 years.

Bio Path Holdings is assigned to the 'Health' sector.

The dividends of Bio Path Holdings are distributed in USD.

All fundamentals and in-depth analysis of Bio Path Holdings

Our stock analysis for Bio Path Holdings stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bio Path Holdings. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Bio Path Holdings Stock
Bio Path Holdings Revenue→
Bio Path Holdings Stock
Bio Path Holdings Net Income→
Bio Path Holdings Stock
Bio Path Holdings P/E→
Bio Path Holdings Stock
Bio Path Holdings P/S→
Bio Path Holdings Stock
Bio Path Holdings EBIT→
Bio Path Holdings Stock
Bio Path Holdings Dividend→
Bio Path Holdings Stock
Bio Path Holdings Directors Dealings→
Bio Path Holdings Stock
Bio Path Holdings Stocks→
Bio Path Holdings Stock
Bio Path Holdings Market capitalization→
Bio Path Holdings Stock
Bio Path Holdings Debt→
Bio Path Holdings Stock
Bio Path Holdings Liabilities→
Bio Path Holdings Stock
Bio Path Holdings Equity→
Bio Path Holdings Stock
Bio Path Holdings AAQS→
Bio Path Holdings Stock
Bio Path Holdings Employees→
Bio Path Holdings Stock
Bio Path Holdings ROE→
Bio Path Holdings Stock
Bio Path Holdings ROA→
Bio Path Holdings Stock
Bio Path Holdings ROCE→
Bio Path Holdings Stock
Bio Path Holdings News→
Bio Path Holdings Stock
Bio Path Holdings Analyst Price Targets→

Health Stocks

Bio Plus CoBio Green Med SolutionBio Preventive MedicineBinex CoBio Rad LaboratoriesBimergen EnergyBio Solution CoBillionToOneBio ViewBilcareBio-FD&C CoBide Pharmatech CoAll Stocks A–Z →